Order Article Reprints

Moon D-H, Kim A, Song B-W, Kim Y-K, Kim G-T, Ahn E-Y, So M-W, Lee S-G. High Baseline Neutrophil-to-Lymphocyte Ratio Could Serve as a Biomarker for Tumor Necrosis Factor-Alpha Blockers and Their Discontinuation in Patients with Ankylosing Spondylitis. Pharmaceuticals. 2023; 16(3):379. https://doi.org/10.3390/ph16030379

Moon, Dong-Hyuk, Aran Kim, Byung-Wook Song, Yun-Kyung Kim, Geun-Tae Kim, Eun-Young Ahn, Min-Wook So, and Seung-Geun Lee. 2023. "High Baseline Neutrophil-to-Lymphocyte Ratio Could Serve as a Biomarker for Tumor Necrosis Factor-Alpha Blockers and Their Discontinuation in Patients with Ankylosing Spondylitis" Pharmaceuticals 16, no. 3: 379. https://doi.org/10.3390/ph16030379

Moon, D.-H., Kim, A., Song, B.-W., Kim, Y.-K., Kim, G.-T., Ahn, E.-Y., So, M.-W., & Lee, S.-G. (2023). High Baseline Neutrophil-to-Lymphocyte Ratio Could Serve as a Biomarker for Tumor Necrosis Factor-Alpha Blockers and Their Discontinuation in Patients with Ankylosing Spondylitis. Pharmaceuticals, 16(3), 379. https://doi.org/10.3390/ph16030379